Drug Discovery & Pharmaceuticals

RSS

Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform

Recently, researchers discuss their development of cell membrane-based nanoparticles that successfully delivered dexamethasone directly to inflamed lung cells.

21 Jun 2021

Tiny capsules containing cannabinoids could help treat neurological disorders

A team of researchers led by Curtin University has discovered a new way to improve the absorption rate of medicinal cannabis when taken orally, which could potentially be used to treat neurological disorders such as Alzheimer’s disease, multiple sclerosis and traumatic brain injuries in the future.

21 Jun 2021

Novel drug class shows potential to treat cancer patients with faulty BRCA genes

Scientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumors have faulty copies of the BRCA cancer genes.

17 Jun 2021

Toxicant profile of BAT's modern oral products is comparable to nicotine replacement therapies

New research published today indicates that BAT's modern oral (MO) products in the form of tobacco-free nicotine pouches have a toxicant profile that is comparable to nicotine replacement therapies (NRTs) and much lower than traditional oral snus, a category of products that, when used as the sole nicotine product is already established as a reduced risk product compared with cigarettes.

17 Jun 2021

New computational topology strategy to identify existing medicines for treating COVID-19

Researchers from the ESI International Chair of the CEU Cardenal Herrera University (CEU UCH) and ESI Group have just published in scientific journal Pharmaceutics a new computational topology strategy to identify existing medicines that could be applied to treat COVID-19 without waiting for the research and clinical trial phases required to develop a new medicine.

16 Jun 2021

The Role of Nanoparticles for Drug Delivery

In this interview, Mark Bumiller, Technology Manager at Entegris talks to News Medical Life Sciences about the role nanoparticles can play in drug delivery.

From Entegris, Inc. 15 Jun 2021

Virginia Tech researcher receives $2.2 million to advance study on small 'fat burning' molecules

The liver is the most resilient organ in the human body. It can remove toxins from the bloodstream, recycle red blood cells, maintain sugar levels, and it can even regenerate itself. But, when a large amount of fat builds up in the liver, it becomes too inflamed to perform its crucial duties.

14 Jun 2021

UCSF launches new initiative to propel the development of living therapeutics

UC San Francisco is launching a new initiative to propel the development of living therapeutics - a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease - and bring them quickly to patients.

14 Jun 2021

Common antidepressant drugs help the immune system to attack tumors in mice

A class of drug called monoamine oxidase inhibitors is commonly prescribed to treat depression; the medications work by boosting levels of serotonin, the brain's "happiness hormone."

10 Jun 2021

New resin acid molecules have promising properties as potential drugs against epilepsy

New molecules, developed by researchers at Linköping University, have promising properties as possible drugs against epilepsy.

8 Jun 2021

Autobahn Labs collaborates with CSHL to advance science from the lab to clinic

Autobahn Labs, an early-stage drug discovery incubator, today announced a new strategic venture collaboration with Cold Spring Harbor Laboratory.

7 Jun 2021

Rice scientist wins NIH grant to model and analyze protein-ligand interactions in cancer research

Computer scientist Lydia Kavraki of Rice University's Brown School of Engineering has won a prestigious National Institutes of Health U01 grant to develop a new approach to model and analyze protein-ligand interactions in cancer research.

7 Jun 2021

Research opens alternative therapeutic avenues for treatment of chronic pain

Building on previous findings, scientists have demonstrated that conolidine interacts with the newly identified opioid receptor ACKR3/CXCR7.

3 Jun 2021

Scientists identify many existing drugs with antiviral activity against coronavirus

Mining the world's most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that's driving the ongoing global pandemic.

3 Jun 2021

Streamline Cannabinoid Analyses with Restek’s New Neutrals Mix

Restek’s new cannabinoid 9-component mix streamlines cannabinoid analyses.

From Restek Corporation 3 Jun 2021

How bacterial cells have been engineered to produce virus-resistant synthetic polymers

A recent Science paper discusses the utilization of a previously reported synthetic Escherichia coli to produce virus-resistant synthetic polymers.

3 Jun 2021

NUS researchers develop a way to automate the production of pharmaceutical small molecules

The discovery and development of new small-molecule compounds for therapeutic use involves a huge investment of time, effort and resources.

1 Jun 2021

Students isolate 570 microbes from soil samples to identify new antibiotics

The 57 Valencian students who have taken part in the "En busca de nuevos Fleming" (Searching for the new Fleming) project of the SWICEU team, have showcased their results in an event held at the assembly room of the CEU Cardenal Herrera university.

17 May 2021

Researchers identify new compound that may prevent cardiac arrhythmia risk from common drugs

Dozens of commonly used drugs, including antibiotics, antinausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long QT syndrome.

14 May 2021

New peptide could allow cannabis to fight pain without side effects

Many people live with chronic pain, and in some cases, cannabis can provide relief. But the drug also can significantly impact memory and other cognitive functions.

12 May 2021

Drug Discovery & Pharmaceuticals

Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform

Tiny capsules containing cannabinoids could help treat neurological disorders

Novel drug class shows potential to treat cancer patients with faulty BRCA genes

Toxicant profile of BAT's modern oral products is comparable to nicotine replacement therapies

New computational topology strategy to identify existing medicines for treating COVID-19

The Role of Nanoparticles for Drug Delivery

Virginia Tech researcher receives $2.2 million to advance study on small 'fat burning' molecules

UCSF launches new initiative to propel the development of living therapeutics

Common antidepressant drugs help the immune system to attack tumors in mice

New resin acid molecules have promising properties as potential drugs against epilepsy

Autobahn Labs collaborates with CSHL to advance science from the lab to clinic

Rice scientist wins NIH grant to model and analyze protein-ligand interactions in cancer research

Research opens alternative therapeutic avenues for treatment of chronic pain

Scientists identify many existing drugs with antiviral activity against coronavirus

Streamline Cannabinoid Analyses with Restek’s New Neutrals Mix

How bacterial cells have been engineered to produce virus-resistant synthetic polymers

NUS researchers develop a way to automate the production of pharmaceutical small molecules

Students isolate 570 microbes from soil samples to identify new antibiotics

Researchers identify new compound that may prevent cardiac arrhythmia risk from common drugs

New peptide could allow cannabis to fight pain without side effects

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News